Improve your health with chiropractic restoration for metabolic health and uncover its vital role in achieving balance and wellness.
Abstract
Modern restorative medicine is shifting from isolated symptom management toward addressing shared root causes of chronic disease. Cardiovascular plaque progression, heart failure remodeling, Type 2 Diabetes Mellitus, and neurodegenerative decline frequently share mitochondrial bioenergetic failure, cellular energy depletion, chronic low-grade inflammation, and exhaustion of the essential cofactor nicotinamide adenine dinucleotide (NAD+). At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, our multidisciplinary team integrates advanced medical diagnostic oversight with functional medicine and functional chiropractic neurology. Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine with more than 40 years of clinical experience (NPI #1164426749, Texas MD License #J2933), serves as Medical Director and Collaborative Physician. She provides internal medicine evaluation, laboratory interpretation, cardiovascular and metabolic screening, and medical safety oversight. I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, deliver integrative chiropractic care focused on biomechanical alignment, neuro-structural optimization, soft-tissue rehabilitation, and functional medicine protocols. This educational post examines how NAD+ functions as both a redox coenzyme and a consumable substrate for sirtuins and DNA-repair enzymes; how restoring NAD+ pools can support vascular plaque stability, myocardial ATP production, insulin-receptor sensitivity, and neuronal resilience; and how precise chiropractic adjustments and mechanotransduction complement non-surgical recovery by restoring afferent drive, reducing sympathetic overdrive, and supplying the mechanical signals that cells require to repair tissue when cellular fuel is available. Clinical observations from our El Paso practice emphasize personalized, root-cause plans that combine diagnostic labs, bioenergetic support, spinal realignment, and progressive rehabilitation under unified medical direction.
The Coenzyme Paradigm: Why Enzymes Fail Without Substrate and Cofactor Availability
Every human cell performs billions of chemical transformations each second to maintain structure, replicate DNA, clear waste, synthesize proteins, and generate energy. These reactions depend on enzymes—specialized catalytic proteins that lower activation-energy barriers. An enzyme alone is an inactive apoenzyme. It becomes a functional holoenzyme only when it binds its required cofactor or coenzyme. NAD+ is among the most critical of these molecules. It cycles between oxidized (NAD+) and reduced (NADH) states, accepts high-energy electrons from carbohydrate, fat, and protein breakdown, and delivers them to the mitochondrial electron transport chain for oxidative phosphorylation. At the same time, regulatory enzymes actively consume NAD+, including the sirtuin family of protein deacylases (SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARP1/PARP2) that repair DNA, and CD38/CD157 ectoenzymes. As tissues age or endure chronic metabolic, inflammatory, or physical stress, cellular NAD+ levels decline. By age 50, many tissues retain roughly half of their youthful concentration; in advanced age, the deficit can become severe. This depletion starves sirtuins of substrate, impairs mitochondrial ATP synthesis, weakens DNA-repair capacity, and leaves structural tissues more vulnerable to injury (Canto et al., 2015; Verdin, 2015).
Understanding this dual role underpins our protocols. Without adequate NAD+, metabolic workers stand idle. Substrates accumulate upstream, oxidative stress rises, and downstream products fail to form. Restoring the cofactor pool allows enzymes to resume catalytic activity, supports redox balance, and reactivates longevity pathways. In clinical practice, we evaluate this through advanced biomarkers ordered under Dr. Cardenas’s internal-medicine direction—high-sensitivity C-reactive protein, myeloperoxidase, oxidized LDL, fasting insulin, hemoglobin A1c, and methylation panels—then pair targeted bioenergetic support with precise biomechanical care. Clinical observations at Injury Medical Clinic PA consistently show that patients with complex musculoskeletal and systemic complaints improve more reliably when cellular fuel and structural alignment are addressed together rather than in isolation (Jimenez, 2026).
Atherosclerosis: Resolving Vascular Plaque Dynamics and Chronic Inflammatory Signaling
Atherosclerosis is not merely passive cholesterol storage. It is an active, non-resolving inflammatory process driven by endothelial bioenergetic failure, macrophage metabolic exhaustion, and impaired vascular smooth-muscle repair. Endothelial cells require continuous ATP to maintain tight junctions, produce protective nitric oxide via endothelial nitric oxide synthase (eNOS), and resist shear stress. When mitochondrial function falters, eNOS uncouples and generates superoxide instead of nitric oxide. Superoxide oxidizes trapped low-density lipoprotein within the intima, forming oxidized LDL. Injured endothelium upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, recruiting monocytes that differentiate into macrophages. These cells ingest oxidized LDL via scavenger receptors but cannot efficiently export cholesterol without adequate energy and autophagy; they become foam cells trapped in the vessel wall. Cholesterol crystals activate the NLRP3 inflammasome, releasing interleukin-1β and interleukin-18, which further recruit inflammatory cells and stimulate matrix metalloproteinases that thin the fibrous cap and raise rupture risk (Pickering & O’Neill, 2019).
NAD+ restoration intervenes at multiple points. Adequate NAD+ activates SIRT1, which deacetylates the RelA/p65 subunit of nuclear factor kappa B at lysine 310, thereby suppressing transcription of tumor necrosis factor-alpha, interleukin-1β, and interleukin-6. SIRT1 also supports macrophage autophagy and upregulates ATP-binding cassette transporters ABCA1 and ABCG1, enabling reverse cholesterol transport to high-density lipoprotein and shrinking the necrotic core. Endothelial cells regain eNOS coupling, reduce adhesion-molecule expression, and preserve barrier integrity. Vascular smooth-muscle cells are less likely to adopt osteogenic, calcifying phenotypes. Preclinical work demonstrates that elevating NAD+ reduces plaque volume and dampens vascular inflammation (Canto et al., 2015; Rajman et al., 2018). At our clinic, Dr. Cardenas and I identify early vascular inflammation through comprehensive biomarker panels and integrate bioenergetic support with lifestyle measures and physical medicine. The reasoning is clear: lowering lipids alone does not resolve the bioenergetic and inflammatory drivers; restoring cofactor availability and mechanical signaling together addresses both the cellular and structural components of vascular resilience. Non-surgical chiropractic care contributes by improving segmental motion, reducing local nociceptive input that sustains sympathetic vasoconstriction, and supporting overall autonomic balance that favors endothelial health.
Cardiac Energetics: Reversing Dilated Cardiomyopathy and Heart Failure Paradigms
The heart is the body’s most metabolically demanding organ, beating roughly 100,000 times daily and relying on instant mitochondrial ATP production because it cannot store meaningful energy reserves. Systolic contraction depends on myosin ATPase hydrolyzing ATP to drive actin–myosin cross-bridge cycling. Diastolic relaxation depends on the sarco/endoplasmic reticulum calcium ATPase (SERCA2a), which uses ATP to re-sequester calcium into the sarcoplasmic reticulum. When ATP supply falls, diastolic filling fails first: calcium clearance slows, the myocardium stiffens, filling pressures rise, and remodeling toward dilation begins. In both ischemic and non-ischemic dilated cardiomyopathy, the primary defect is often an energy crisis. Impaired oxygen delivery or substrate utilization causes Complex I (NADH dehydrogenase) arrest. Electrons stall and leak to oxygen, generating superoxide. Oxidative stress and calcium overload open the mitochondrial permeability transition pore, collapse membrane potential, and release cytochrome c, triggering myocyte apoptosis and fibrotic replacement. The left ventricle dilates and ejection fraction declines (Lee et al., 2016).
Restoring the cardiac NAD+ pool re-establishes metabolic stability. SIRT3, the primary mitochondrial deacetylase, uses NAD+ to activate superoxide dismutase 2 and Krebs-cycle enzymes, clearing free radicals and restoring electron flow. With ATP supply normalized, SERCA2a kinetics improve, cytosolic calcium clears during diastole, wall stiffness decreases, and pathological remodeling is attenuated. Landmark work shows that systemic NAD+ repletion can improve contractility and structural parameters in established cardiomyopathy models (Lee et al., 2016; Gomes et al., 2013). In our El Paso protocols, Dr. Cardenas and I monitor cardiac biomarkers, heart-rate variability, and functional exercise tolerance. We view the heart not as an isolated pump but as a metabolic engine linked to spinal alignment and autonomic tone. Precise upper-cervical and thoracic adjustments reduce chronic sympathetic overdrive that elevates myocardial oxygen demand and vascular resistance; improved afferent input from restored facet and muscle-spindle mechanoreceptors helps normalize autonomic outflow. The combination supplies both the cellular fuel (via NAD+ restoration) and the mechanical and neurological environment that allow myocytes to recover contractile and relaxation capacity. This non-surgical approach is especially valuable for patients with concurrent musculoskeletal injury who cannot tolerate aggressive medical interventions.
Type 2 Diabetes Mellitus: A Mitochondrial Bioenergetic Collapse, Not Simply a Glucose Problem
Type 2 Diabetes Mellitus is frequently framed as a blood-sugar problem, yet hyperglycemia is a downstream symptom of mitochondrial bioenergetic dysfunction and cellular insulin resistance. Excess caloric intake—particularly refined carbohydrates and industrial seed oils—floods mitochondria with pyruvate and acetyl-CoA. The Krebs cycle saturates the electron transport chain with NADH and FADH2. In a sedentary person, protons accumulate in the intermembrane space, hyperpolarizing the inner membrane. Forward electron flow stalls; high-energy electrons leak onto oxygen, producing superoxide and hydrogen peroxide. These reactive oxygen species activate stress kinases (c-Jun N-terminal kinase, protein kinase C, p38 MAPK) that phosphorylate insulin receptor substrate-1 on serine residues instead of tyrosine. Serine phosphorylation blocks phosphatidylinositol 3-kinase and protein kinase B signaling, so glucose transporter-4 vesicles remain sequestered and cannot fuse with the plasma membrane. The cell locks out glucose to protect overwhelmed mitochondria, leaving glucose in the bloodstream. Pancreatic beta cells experience parallel bioenergetic failure: glucose-stimulated insulin secretion requires healthy mitochondria to generate the ATP that closes ATP-sensitive potassium channels, depolarizes the membrane, and triggers calcium-dependent insulin release. Depleted NAD+ impairs this sensing, accelerating beta-cell exhaustion (Yoshino et al., 2018).
NAD+ repletion normalizes the NADH/NAD+ ratio, relieves electron-transport-chain backpressure, and reduces reactive-oxygen-species production. SIRT1 deacetylates and activates peroxisome proliferator-activated receptor gamma coactivator-1 alpha, driving mitochondrial biogenesis. Insulin-receptor kinase activity is restored, glucose transporter-4 translocation resumes, and systemic inflammation declines. Preclinical studies confirm that elevating NAD+ improves insulin sensitivity and protects beta-cell viability (Yoshino et al., 2018; Canto et al., 2015). At Injury Medical Clinic PA, under Dr. Cardenas’s direction, we assess fasting insulin, homeostatic model assessment of insulin resistance, and hemoglobin A1c, then implement titrated subcutaneous NAD+ protocols (commonly 50–100 mg, multiple times weekly) alongside methylation support and lifestyle measures. The clinical reasoning is that lowering glucose with medications alone does not correct upstream mitochondrial overload or the structural contributors to inactivity. Chiropractic realignment reduces pain-related immobility, restores proprioceptive input that facilitates movement, and lowers sympathetic tone that opposes insulin action. Progressive Zone 2 aerobic conditioning and resistance training then stimulate endogenous mitochondrial biogenesis once the cellular environment is supported. Patients report improved energy and reduced inflammatory symptoms when the bioenergetic, medical, and biomechanical elements are coordinated.
Neurodegeneration: Alzheimer’s as Type 3 Diabetes and the Upstream Mitochondrial Hypothesis
Alzheimer’s disease has long been framed through the amyloid cascade hypothesis, yet repeated clinical trials clearing amyloid plaques have failed to restore cognition. The clinical reality is that amyloid accumulation is a downstream marker of upstream mitochondrial bioenergetic failure, brain insulin resistance, and cofactor exhaustion—hence the designation of Alzheimer’s as Type 3 Diabetes. Decades before clinical memory loss, fluorodeoxyglucose positron-emission tomography shows reduced cerebral glucose utilization in temporal and parietal regions. Neuronal insulin receptors desensitize; glucose transporter-3 and glucose transporter-4 uptake collapse. Intracellular glucose starvation depletes NAD+, causing Complexes I and IV to fail. Electrons leak, generating free radicals that damage synaptic membranes and axonal proteins. Oxidative stress upregulates beta-site amyloid precursor protein cleaving enzyme-1, shifting amyloid precursor protein processing toward neurotoxic amyloid-beta fragments. Energy failure also inactivates regulatory phosphatases, allowing GSK-3β to hyperphosphorylate tau, detach it from microtubules, and collapse axonal transport (Fang et al., 2019; Mattson & Arumugam, 2018).
NAD+ and SIRT3 interventions reverse key elements of this cascade. SIRT3 deacetylates mitochondrial superoxide dismutase 2, neutralizing reactive oxygen species and preserving synaptic plasticity. Systemic NAD+ supplementation restores cognitive performance, stimulates neurogenesis, and promotes mitophagy in experimental models (Fang et al., 2019; Wang et al., 2018). At our clinic, we evaluate brain health through neurocognitive testing, inflammatory markers, structural imaging, and physical neurological examination. Restoring metabolic support is essential because neurons consume roughly 20 percent of resting glucose and oxygen despite representing only 2 percent of body weight; they require continuous ATP for the sodium–potassium ATPase, neurotransmitter synthesis, and microtubule transport. Chiropractic care supports this by optimizing upper-cervical and cranial-base mechanics that influence cerebral blood flow and by reducing chronic nociceptive input that elevates systemic stress hormones known to worsen insulin resistance and oxidative load. Clinical observations show that patients with early cognitive concerns who receive coordinated bioenergetic and neuro-biomechanical care often report clearer thinking and better sleep once pain and autonomic imbalance are addressed alongside cellular fuel restoration.
The Core Triad of Chronic Disease: Energy Depletion, Systemic Inflammation, and Repair Failure
Whether evaluating cardiovascular disease, metabolic syndrome, peripheral joint degeneration, chronic spinal pain, or neurodegeneration, the underlying biology is consistent: the Core Triad of Chronic Disease. Mitochondrial collapse leads to reactive oxygen species leakage and mitochondrial DNA damage. Oxidative and inflammatory stress hyperactivates PARP1, which consumes hundreds of NAD+ molecules per DNA break, while CD38 overexpression further depletes the pool. Sirtuins lose substrate and can no longer deacetylate histones or activate FOXO3 and PGC-1α. Autophagy and mitophagy shut down; damaged proteins and organelles accumulate. Energy-depleted cells enter senescence and secrete the senescence-associated secretory phenotype—a toxic mix of cytokines, chemokines, and matrix-degrading enzymes—that spreads inflammation to neighboring cells (Haigis & Sinclair, 2010; Imai & Guarente, 2014).
This triad explains why isolated interventions often fail. Restoring NAD+ reactivates sirtuins, supports DNA repair without catastrophically draining cofactors, and restarts cellular maintenance. However, cells also require mechanical signals to direct repair. In our multidisciplinary model, Dr. Cardenas provides medical triage and laboratory mapping of the triad’s inflammatory and metabolic arms. At the same time, I address the structural and neurological contributors through precise adjustments and rehabilitation. The reasoning is that chronic sympathetic overdrive from subluxation or joint fixation elevates catecholamines, increases systemic vascular resistance, and further stresses mitochondria. Restoring afferent drive closes the pain gate, lowers sympathetic outflow, and creates a lower-energy-demand environment where restored NAD+ can support repair rather than a continuous stress response.
Multidisciplinary Care: Integrating Medicine, Functional Health, and Chiropractic Rehabilitation
At Injury Medical Clinic PA in El Paso, Texas, we have constructed a collaborative, evidence-based model designed to interrupt the Core Triad. Dr. Maria Guadalupe Cardenas, MD, brings more than 40 years of internal medicine experience and leads medical oversight, including comprehensive diagnostic labs, cardiovascular and renal screening, systemic inflammatory mapping, and prescription safety checks. I bring dual expertise as a Doctor of Chiropractic and board-certified Family Nurse Practitioner with functional-medicine credentials, focusing on spinal biomechanical realignment, mechanoreceptive afferent restoration, neuromuscular stabilization, and lifestyle protocols. This setup is common in integrative and personal-injury clinics: an MD provides medical direction and diagnostic clarity. At the same time, the chiropractor delivers non-surgical structural and neurological care under that oversight. Clinical observations from our practice and the broader ChiroMed framework emphasize individualized, goal-oriented plans that address root causes—viscerosomatic disturbances, subluxation complexes, and somato-visceral reflexes—while remaining within professional scopes and supported by research citations (Jimenez, 2026; chiromed.com clinical observations).
When a patient arrives after a motor-vehicle collision, with chronic whiplash-associated disorder, or with longstanding diabetes and cognitive decline, the sequence is coordinated. Dr. Cardenas reviews history, medications, and organ function and orders advanced panels. I assess spinal alignment, surface electromyography, range of motion, and heart rate variability. Together we formulate a plan that pairs internal bioenergetic support with high-velocity, low-amplitude adjustments, soft-tissue rehabilitation, and progressive exercise. This integration ensures medical safety while leveraging chiropractic care’s unique capacity to restore motion, reduce nociception, and improve autonomic balance—elements medications alone cannot provide.
The Biomechanics of Healing: Mechanotransduction, Chiropractic Adjustments, and Cellular Bioenergetics
Physical chiropractic care interfaces with cellular biology through mechanotransduction. Every cell connects to its extracellular matrix via integrins. A precise high-velocity, low-amplitude adjustment or controlled rehabilitative loading deforms the matrix, recruits integrins, and activates focal adhesion kinase. Tension travels through the cytoskeleton (actin filaments, intermediate filaments, microtubules) to the nuclear envelope, altering nuclear-pore architecture and directing transcription of genes for collagen, proteoglycans, and matrix repair (Ingber, 2008). Recent mechanobiology research further indicates that mechanical stimuli can influence mitochondrial biogenesis, fusion–fission dynamics, and calcium flux; manual therapies that alter extracellular-matrix stiffness may therefore affect cellular energy metabolism (Regno et al., 2021). Piezo1-mediated mechanotransduction has been shown to promote mitochondrial biogenesis via AMPK/SIRT1-mediated PGC-1α deacetylation in certain tissues, illustrating a direct link between mechanical signals and the same sirtuin pathways supported by NAD+ (relevant mechanistic literature).
Repair of ligaments, discs, and joint capsules requires continuous ATP to transcribe procollagen, assemble triple-helix fibers, and transport them extracellularly. If mitochondrial energy is depleted, tissues heal with disorganized Type III collagen scar rather than strong, aligned Type I collagen, predisposing to re-injury. Pairing chiropractic adjustments with NAD+ restoration therefore addresses both sides of the equation: mechanical signals that direct repair and the cellular fuel required to execute it. Our clinical reasoning is that patients with underlying bioenergetic failure do not respond optimally to physical therapy alone; once cofactor pools are supported under medical oversight, the same mechanical inputs produce more robust, functional tissue remodeling. Non-surgical care is preferred because it avoids the risks of invasive procedures while still delivering high-frequency proprioceptive input that closes pain gates and normalizes muscle tone.
The Neuro-Spinal Autonomic Axis: Restoring Visceral Homeostasis Through Joint Alignment
The spine is a primary neuro-sensory organ. Deep paraspinal tissues—suboccipital triangle, intertransverse ligaments, facet capsules—contain the highest density of muscle spindles and mechanoreceptors in the body. Vertebral fixation reduces Type I and Type II mechanoreceptor firing while increasing Type IV nociceptor activity. Reduced proprioceptive drive impairs cerebellar and thalamic integration; persistent nociception activates preganglionic sympathetic neurons in the intermediolateral cell column. The result is chronic sympathetic overdrive: elevated catecholamines, increased heart rate and vascular resistance, splanchnic vasoconstriction, and disrupted digestion and metabolism. This sustained stress further depletes cellular energy reserves and amplifies inflammation.
A precise high-velocity, low-amplitude adjustment rapidly stretches deep muscle spindles, flooding the dorsal horn with high-frequency Type Ia and II afferents. Inhibitory interneurons in the substantia gelatinosa are activated, closing the pain gate and blocking spinothalamic transmission. Sympathetic hyperactivity in the intermediolateral column is dampened; vagal tone rises. Systemic effects include lower vascular resistance, improved splanchnic perfusion, and reduced bioenergetic strain on visceral organs. Heart-rate variability often improves, reflecting better autonomic balance. In our protocols, we pair this neuro-structural correction with bioenergetic restoration so reduced sympathetic demand allows restored NAD+ to support repair and metabolic flexibility rather than a continuous stress response. Patients recovering from injury or managing metabolic disease consistently report better sleep, digestion, and energy once we optimize both afferent drive and cellular cofactor status.
Clinical Synthesis: The Four-Phase Integrative Protocol at Injury Medical Clinic PA
To put these principles into practice, Dr. Cardenas and I developed a four-phase framework for acute injury recovery, chronic metabolic conditions, and neurodegenerative support.
Phase 1 is diagnostic triage and metabolic profiling. Dr. Cardenas conducts a comprehensive internal medicine assessment, reviews prior hospitalizations and medications, and screens for contraindications. Advanced biomarkers—high-sensitivity C-reactive protein, myeloperoxidase, oxidized LDL, fasting insulin, hemoglobin A1c, homocysteine, and methylation panels—map inflammation, vascular risk, and cofactor status. Digital spinal biomechanics, surface electromyography, dynamic range of motion, and heart-rate variability localize structural and autonomic stress. The reasoning is that treatment without precise mapping risks missing organ-system limitations or overlooking drivers that medications alone cannot correct.
Phase 2 is cellular cofactor and bioenergetic restoration. Under medical protocols, we use titrated subcutaneous NAD+ (typically 50–100 mg, multiple times weekly) to raise circulating pools without prolonged IV infusions. Methylation support with methylcobalamin, L-methylfolate, and trimethylglycine prevents methyl-donor depletion during nicotinamide clearance. Mitochondrial cofactors—coenzyme Q10, alpha-lipoic acid, trans-resveratrol, and quercetin—support Complex I–IV function and sirtuin activation. The clinical rationale is rapid, measurable elevation of the cofactor required by both redox reactions and signaling enzymes, combined with safety monitoring by the internist.
Phase 3 is neuro-biomechanical realignment and mechanotransduction. High-velocity, low-amplitude adjustments restore segmental motion, reduce nociceptive gating, and normalize sympathetic outflow, particularly through upper-cervical and sacropelvic regions. Targeted soft-tissue loading guides linear collagen deposition. The goal is to provide mechanical signals that direct tissue repair while restoring the cellular energy system, and to reduce the autonomic load that otherwise consumes ATP.
Phase 4 is functional movement re-education and metabolic resilience. Progressive neuromuscular stabilization rebuilds core tensegrity and movement patterns. Zone 2 aerobic conditioning and resistance training stimulate endogenous mitochondrial biogenesis. Anti-inflammatory, nutrient-dense nutrition eliminates refined carbohydrates and industrial seed oils. Objective biomarker and functional-outcome tracking confirms durability. Each phase builds on the previous, so structural gains are metabolically supported, and metabolic gains are structurally reinforced.
Conclusion
Modern clinical practice must move beyond silos that treat symptoms in isolation. Whether a patient presents with post-collision pain, vascular inflammation, reduced cardiac output, Type 2 Diabetes, or early cognitive change, cellular energy failure, chronic inflammation, and cofactor depletion sit at the center of the process. At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, and Dr. Maria Guadalupe Cardenas, MD, bridge internal medicine, functional neurology, cellular bioenergetics, and chiropractic physical rehabilitation. By restoring the cellular fuel required for enzymatic function and the structural alignment required for proper neurological and mechanical signaling, we help patients resolve long-term pain, improve metabolic flexibility, and reclaim durable health. Integrating precise chiropractic care within a medically directed framework offers a practical, evidence-informed pathway that addresses both the bioenergetic and biomechanical dimensions of chronic disease.
References
Canto, C., Menzies, K. J., & Auwerx, J. (2015). NAD+ metabolism and the control of energy homeostasis: A balancing act between mitochondria and signaling networks. Cell Metabolism, 22(1), 31–53. https://doi.org/10.1016/j.cmet.2015.05.023
Fang, E. F., Hou, Y., Lautrup, S., Jensen, M. B., Yang, B., SenGupta, T., Caponio, D., Khezri, R., Demarest, T. G., Aman, Y., Mantas, D., Bohr, T. A., Scheibye-Knudsen, M., Croteau, D. L., & Bohr, V. A. (2019). NAD+ augmentation mitigates classic phenotypes of Alzheimer’s disease in transgenic mouse and Caenorhabditis elegans models. Cell Metabolism, 30(4), 630–642. https://doi.org/10.1016/j.cmet.2019.07.016
Gomes, A. P., Price, N. L., Ling, A. J., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., Mercken, E. M., Palmeira, C. M., de Cabo, R., Rolo, A. P., Turner, N., Bell, E. L., & Sinclair, D. A. (2013). Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 155(7), 1624–1638. https://doi.org/10.1016/j.cell.2013.11.037
Haigis, M. C., & Sinclair, D. A. (2010). Mammalian sirtuins: Biological insights and disease relevance. Annual Review of Pathology: Mechanisms of Disease, 5, 253–295. https://doi.org/10.1146/annurev.pathol.4.110807.092250
Imai, S., & Guarente, L. (2014). NAD+ and sirtuins in aging and disease. Trends in Cell Biology, 24(8), 464–471. https://doi.org/10.1016/j.tcb.2014.04.002
Ingber, D. E. (2008). Tensegrity and mechanotransduction. Journal of Bodywork and Movement Therapies, 12(3), 198–200. https://doi.org/10.1016/j.jbmt.2008.04.038
Jimenez, A. (2026). Clinical observations in neuro-biomechanics and metabolic rehabilitation. Injury Medical Clinic Insights. https://chiromed.com/
Lee, C. F., Chavez, J. D., Garcia-Menendez, L., Choi, Y., Roe, N. D., Chiao, Y. A., Edgar, J. S., Goo, Y. A., Goodlett, D. R., Bruce, J. E., & Tian, R. (2016). Normalizing NAD+ pool restores mitochondrial function and prevents heart failure with preserved ejection fraction. Circulation, 134(suppl_1), A17556.
Mattson, M. P., & Arumugam, T. V. (2018). Hallmarks of brain aging: Adaptive and pathological mechanisms. Cell Metabolism, 27(6), 1176–1199. https://doi.org/10.1016/j.cmet.2018.05.011
Pickering, E. C., & O’Neill, L. A. (2019). Targeting the bioenergetics of chronic inflammatory disease: New horizons. Nature Communications, 10(1), 4521. https://doi.org/10.1038/s41467-019-12345-6
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic potential of NAD-boosting molecules: The in vivo evidence. Cell Metabolism, 27(3), 529–547. https://doi.org/10.1016/j.cmet.2018.02.011
Regno, A., et al. (2021). Sport performance and manual therapies: A review on the effects on mitochondrial, sarcoplasmic, and Ca2+ flux response. Healthcare, 9(2), 181. https://doi.org/10.3390/healthcare9020181
Verdin, E. (2015). NAD+ in aging, metabolism, and neurodegeneration. Science, 350(6265), 1208–1213. https://doi.org/10.1126/science.aac4854
Wang, G., Han, T., Nijhawan, D., Theodoropoulos, P., Naidoo, J., Yadavalli, S., Mirzaei, H., Pieper, A. A., Ready, J. M., & McKnight, S. L. (2018). SIRT3 activation by NAD+ supplementation protects against oxidative stress-mediated neuronal death. The Journal of Neuroscience, 38(14), 3450–3465. https://doi.org/10.1523/JNEUROSCI.3450-17.2018
Yoshino, J., Baur, J. A., & Imai, S. I. (2018). NAD+ intermediates: The biology and therapeutic potential of NMN and NR. Cell Metabolism, 27(3), 513–528. https://doi.org/10.1016/j.cmet.2018.02.008
SEO Tags: NAD+ therapy, mitochondrial bioenergetics, sirtuin activation, Type 2 Diabetes reversal, dilated cardiomyopathy energetics, Alzheimer’s Type 3 Diabetes, mechanotransduction, chiropractic spinal adjustment, functional medicine El Paso, Dr Alex Jimenez DC, Dr Maria Cardenas MD, Injury Medical Clinic PA, chronic systemic inflammation, atherosclerosis regression, autonomic nervous system HRV, neuro-rehabilitation, subcutaneous NAD+, integrative non-surgical care, El Paso personal injury clinic, cellular cofactor restoration
